Convergent Therapeutics blue logo

Our Team

Founded by world-renowned physicians. Led by a team of clinical and scientific innovators.

Philip Kantoff, MD, CEO & Co-Founder at Convergent Therapeutics
Philip Kantoff, MD

CEO / CMO / Co-Founder

Neil Bander, MD, Founder of Convergent Therapeutics

Neil Bander, MD

CSO / Founder

Alex Brown, MBA, COO at Convergent Therapeutics

Alex Brown, MBA

COO

Eric M. Sullivan, CPA

CFO

Dimitris Voliotis, MD

Senior Vice President of Clinical Development

John Cullity, MD, MBA, Chief Business Advisor at Convergent Therapeutics

John Cullity, MD, MBA

Chief Business Advisor

Nicole Schreiber, Sr. Dir. of Clinical Strategy at Convergent Therapeutics

Nicole Schreiber

Sr. Director, Clinical Strategy

Michele Scarlata

Executive Administrative Partner

Shankar Vallabhajosula, Ph.D.

Vice President of Radiopharmaceutical Sciences

Kyu Jun Son, MD

Sr. Director, Corporate Development

Our Board

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Board Member

Board Member Title

Board Member

Board Member Title

Board Member

Board Member Title

Board Member

Board Member Title

Board Member

Board Member Title

Board Member

Board Member Title

Back to top

Convergent Therapeutics, Inc. is a biotechnology company focused on developing next-generation targeted radiotherapies to treat cancer.

Company

Connect

Contact

[email protected]